MediPharm Labs Announces $2.1M Debt Repayment

Company Now Materially Debt Free with Over $13M in Cash TORONTO, Sept. 17, 2024 /PRNewswire/ – MediPharm Labs Corp. (“MediPharm” or the “Company”) (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health products, is pleased to announce that it…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.